1. State of the Journal 2010: Managing Growth, Extending Our Reach—Now the Official Journal for the Society of Surgical Oncology and the American Society of Breast Surgeons

   • Mark Roh
   • Deborah Whippen
   • Charles Balch

   Editorial Open access 16 December 2009 Pages: 1 - 3

   

2. The National Cancer Data Base: Past, Present, and Future

   • David P. Winchester
   • Andrew K. Stewart
   • Elizabeth E. Ward

   Healthcare Policy and Outcomes Open access 22 October 2009 Pages: 4 - 7

3. Briefings, Checklists, Geese, and Surgical Safety

   • Richard Karl

   John Wayne Clinical Research Lecture-2009 Society of Surgical Oncology Annual Cancer Symposium 10 November 2009 Pages: 8 - 11

4. Surgery for Esophageal Cancer: Quality of Life Matters

   • Jonathan C Salo

   Gastrointestinal Oncology Open access 23 October 2009 Pages: 12 - 13

5. Targeting Gastric Cancer with Trastuzumab: New Clinical Practice and Innovative Developments to Overcome Resistance

   • Dimitrios H. Roukos

   Gastrointestinal Oncology Open access 20 October 2009 Pages: 14 - 17

   

6. Survival and the Sentinel Lymph Node in Melanoma

   • Mark Faries

   Melanomas Open access 30 October 2009 Pages: 18 - 20

7. Surgical Treatment of Malignant Peritoneal Mesothelioma: Past, Present, and Future

   • H. Richard Alexander Jr.

   Thoracic Oncology Open access 04 November 2009 Pages: 21 - 22

8. Preoperative and Early Postoperative Quality of Life Predict Survival in Potentially Curable Patients with Esophageal Cancer

   • Mark van Heijl
   • Mirjam A. G. Sprangers
   • Mark I. van Berge Henegouwen

   Healthcare Policy and Outcomes Open access 15 October 2009 Pages: 23 - 30

   

9. Cost-Effectiveness of Prolonged Thromboprophylaxis After Cancer Surgery

   • Ciarán T. Bradley
   • Karen J. Brasel
   • Sam G. Pappas

   Healthcare Policy and Outcomes 26 August 2009 Pages: 31 - 39

   

10. Practice Patterns and Outcomes for Anorectal Melanoma in the USA, Reviewing Three Decades of Treatment: Is More Extensive Surgical Resection Beneficial in All Patients?

    • Douglas M. Iddings
    • Ani J. Fleisig
    • Donald L. Morton

    Healthcare Policy and Outcomes 23 September 2009 Pages: 40 - 44

    

11. Lymph Node Metastases in Diffuse Malignant Peritoneal Mesothelioma

    • Dario Baratti
    • Shigeki Kusamura
    • Marcello Deraco

    Gastrointestinal Oncology 24 October 2009 Pages: 45 - 53

    

12. Follow-Up Strategy After Curative Resection of Gastric Cancer: A Nationwide Survey in Korea

    • Hoon Hur
    • Kyo Young Song
    • Hae Myung Jeon

    Gastrointestinal Oncology 24 September 2009 Pages: 54 - 64

    

13. Influence of Laparoscopic Gastrectomy on the Detection Rate of Free Gastric Cancer Cells in the Peritoneal Cavity

    • Ying-Xue Hao
    • Hua Zhong
    • Bo Tang

    Gastrointestinal Oncology 24 September 2009 Pages: 65 - 72

    

14. Increased Intratumoral Lymphatic Vessel Density Correlates with Lymph Node Metastasis in Early Gastric Carcinoma

    • Kyoungbun Lee
    • Do Joong Park
    • Hye Seung Lee

    Gastrointestinal Oncology 24 September 2009 Pages: 73 - 80

    

15. High Expression of Atypical Protein Kinase C λ/ι in Gastric Cancer as a Prognostic Factor for Recurrence

    • Ryo Takagawa
    • Kazunori Akimoto
    • Shigeo Ohno

    Gastrointestinal Oncology 23 September 2009 Pages: 81 - 88

    

16. High-Level Expression of S100A4 Correlates with Lymph Node Metastasis and Poor Prognosis in Patients with Gastric Cancer

    • Yuan-Yu Wang
    • Zai-Yuan Ye
    • Yong-Quan Chu

    Gastrointestinal Oncology 10 October 2009 Pages: 89 - 97

    

17. Does Chemoradiotherapy Improve Outcomes for Surgically Resected Adenocarcinoma of the Stomach or Esophagus?

    • Naveenraj L. Solomon
    • Michael C. Cheung
    • Leonidas G. Koniaris

    Gastrointestinal Oncology 24 September 2009 Pages: 98 - 108

    

18. Surgery for Gastrointestinal Stromal Tumors of the Duodenum

    • Yu-Wen Tien
    • Chih-Yuan Lee
    • Po-Huang Lee

    Gastrointestinal Oncology 20 October 2009 Pages: 109 - 114

19. Prognostic Value of Metabolic Tumor Volume Measured by ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal Carcinoma

    • Seung Hyup Hyun
    • Joon Young Choi
    • Byung-Tae Kim

    Gastrointestinal Oncology 14 October 2009 Pages: 115 - 122

    

20. Anterior Minithoracotomy: A Direct Approach to the Difficult Hilum for Upper Lobectomy, Pneumonectomy, and Sleeve Lobectomy

    • Brian L. Pettiford
    • Matthew J. Schuchert
    • Rodney J. Landreneau

    Thoracic Oncology 12 November 2009 Pages: 123 - 128

    

21. Sentinel Lymph Node Dissection in Primary Melanoma Reduces Subsequent Regional Lymph Node Metastasis as Well as Distant Metastasis After Nodal Involvement

    • Ulrike Leiter
    • Petra G. Buettner
    • Claus Garbe

    Melanomas 29 October 2009 Pages: 129 - 137

    

22. Sentinel Lymph Node Biopsy in Pediatric and Adolescent Cutaneous Melanoma Patients

    • Robert Howman-Giles
    • Helen M. Shaw
    • John F. Thompson

    Melanomas 12 August 2009 Pages: 138 - 143

    

23. Feasibility of a Lateral Region Sentinel Node Biopsy of Lower Rectal Cancer Guided by Indocyanine Green Using a Near-Infrared Camera System

    • Shingo Noura
    • Masayuki Ohue
    • Yasuhide Miyamoto

    Colorectal Cancer 23 September 2009 Pages: 144 - 151

    

24. Locally Recurrent Rectal Cancer: Prognostic Factors and Long-Term Outcomes of Multimodal Therapy

    • Fabio Pacelli
    • Antonio P. Tortorelli
    • Giovanni B. Doglietto

    Colorectal Cancer 16 October 2009 Pages: 152 - 162

    

25. Liver Resection for Metastatic Melanoma with Postoperative Tumor-Infiltrating Lymphocyte Therapy

    • R. Taylor Ripley
    • Jeremy L. Davis
    • Itzhak Avital

    Hepatobiliary Tumors 24 September 2009 Pages: 163 - 170

    

26. Safety and Efficacy of Microwave Ablation of Hepatic Tumors: A Prospective Review of a 5-Year Experience

    • Robert C. G. Martin
    • Charles R. Scoggins
    • Kelly M. McMasters

    Hepatobiliary Tumors 26 August 2009 Pages: 171 - 178

    

27. A Comparative Study of Antiviral Therapy After Resection of Hepatocellular Carcinoma in the Immune-Active Phase of Hepatitis B Virus Infection

    • Nan Li
    • Eric C. H. Lai
    • Shu-Qun Cheng

    Hepatobiliary Tumors 29 August 2009 Pages: 179 - 185

    

28. Vascular Anomalies Encountered During Pancreatoduodenectomy: Do They Influence Outcomes?

    • Parul J. Shukla
    • Savio G. Barreto
    • Abe Fingerhut

    Hepatobiliary and Pancreatic Tumors 17 October 2009 Pages: 186 - 193

    

29. A Systematic Review of Resectability and Survival After Concurrent Chemoradiation in Primarily Unresectable Pancreatic Cancer

    • Alessio G. Morganti
    • Mariangela Massaccesi
    • Vincenzo Valentini

    Radiation Oncology 24 October 2009 Pages: 194 - 205

30. Perioperative Hyperfractionated High-Dose Rate Brachytherapy for the Treatment of Soft Tissue Sarcomas: Multicentric Experience

    • Jiří Petera
    • Renata Soumarová
    • Milan Vošmik

    Bone and Soft Tissue Sarcomas 27 August 2009 Pages: 206 - 210

    

31. Chordoma of the Mobile Spine and Sacrum: A Retrospective Analysis of a Series of Patients Surgically Treated at Two Referral Centers

    • Silvia Stacchiotti
    • Paolo Giovanni Casali
    • Piero Picci

    Bone and Soft Tissue Sarcomas 22 October 2009 Pages: 211 - 219

    

32. Intra-Individual Comparison of Lymphatic Drainage Patterns Using Subareolar and Peritumoral Isotope Injection for Breast Cancer

    • Regina M. Fearmonti
    • Isis W. Gayed
    • Gildy V. Babiera

    Breast Oncology 13 August 2009 Pages: 220 - 227

    

33. The Effects of Additional Tumor Cavity Sampling at the Time of Breast-Conserving Surgery on Final Margin Status, Volume of Resection, and Pathologist Workload

    • Monica Rizzo
    • Radha Iyengar
    • Marina B. Mosunjac

    Breast Oncology 28 July 2009 Pages: 228 - 234

34. Intraoperative Assessment of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy in Patients with Breast Cancer

    • Isabel T. Rubio
    • Fernando Aznar
    • Jordi Xercavins

    Breast Oncology 24 September 2009 Pages: 235 - 239

    

35. Validation of the Pedigree Assessment Tool (PAT) in Families with BRCA1 and BRCA2 Mutations

    • P. Teller
    • K. F. Hoskins
    • S. G. A. Gabram

    Breast Oncology 18 September 2009 Pages: 240 - 246

36. Prognostic Impact of [¹⁸F] FDG-PET in Operable Breast Cancer Treated with Neoadjuvant Chemotherapy

    • So-Youn Jung
    • Seok-Ki Kim
    • Jungsil Ro

    Breast Oncology 24 September 2009 Pages: 247 - 253

    

37. Influence of Isolated Tumor Cells in Sentinel Nodes on Outcome in Small, Node-Negative (pT1N0M0) Breast Cancer

    • Marjut H. K. Leidenius
    • Jaana H. Vironen
    • Heikki Joensuu

    Breast Oncology 09 October 2009 Pages: 254 - 262

    

38. Recurrence of Adrenal Cortical Carcinoma Following Resection: Surgery Alone Can Achieve Results Equal to Surgery Plus Mitotane

    • Elizabeth G. Grubbs
    • Glenda G. Callender
    • Jeffrey E. Lee

    Endocrine Tumors 23 October 2009 Pages: 263 - 270

    

39. Laparoscopic Versus Open Surgery for Endometrial Cancer: a Minimum 3-Year Follow-Up Study

    • Fabio Ghezzi
    • Antonella Cromi
    • Massimo Franchi

    Gynecologic Oncology 14 October 2009 Pages: 271 - 278

    

40. Prognostic Impact of Additional Extended Surgical Procedures in Advanced-Stage Primary Ovarian Cancer

    • S. Kommoss
    • J. Rochon
    • A. du Bois

    Gynecologic Oncology 07 November 2009 Pages: 279 - 286

41. Immediate Microsurgical Reconstruction After Tumor Ablation Predicts Survival Among Patients with Head and Neck Carcinoma

    • Thomas Mücke
    • Klaus-Dietrich Wolff
    • Frank Hölzle

    Reconstructive Oncology 20 October 2009 Pages: 287 - 295

    

42. Combination Intraperitoneal Chemotherapy Is Superior to Mitomycin C or Oxaliplatin for Colorectal Carcinomatosis In Vivo

    • Mark S. Cohen
    • Mazin F. Al-kasspooles
    • Katherine F. Roby

    Translational Research and Biomarkers 26 August 2009 Pages: 296 - 303

    

43. Thermal Sensitization Using Induced Oxidative Stress Decreases Tumor Growth in an In Vivo Model of Hyperthermic Intraperitoneal Perfusion

    • Reza Razavi
    • Lawrence E. Harrison

    Translational Research and Biomarkers 27 August 2009 Pages: 304 - 311

    

44. Association Analysis of Wnt Pathway Genes on Prostate-Specific Antigen Recurrence After Radical Prostatectomy

    • Shu-Pin Huang
    • Wen-Chien Ting
    • Bo-Ying Bao

    Translational Research and Biomarkers 24 September 2009 Pages: 312 - 322

    

45. Nipple-Sparing Mastectomy: Overcoming Oncological Outcomes Challenges

    • D. Ziogas
    • D. H. Roukos
    • G. C. Zografos

    Breast Oncology 24 September 2009 Pages: 323 - 324

46. Searching for a Cutoff Value for Lymph Nodes Retrieved as a Quality Control of Surgery and Pathology in Colon Cancer

    • B. Papaziogas
    • D. Ziogas

    Colorectal Cancer 15 October 2009 Pages: 325 - 326

47. Invitation to Reply to: Searching for a Cutoff Value of Lymph Nodes Retrieved as a Quality Control of Surgery and Pathology in Colon Cancer (Papaziogas B, Ziogas D. Annals of Surgical Oncology 2009)

    • R. Vather
    • T. Sammour
    • A. G. Hill

    Colorectal Cancer 14 October 2009 Pages: 327 - 328

48. Author Reply: Management of Mild Elevation of Calcitonin After Thyroidectomy

    • Ashok R. Shaha
    • R. Michael Tuttle

    Endocrine Tumors 07 October 2009 Pages: 329 - 330

49. RET Germline Mutations in Codon 609 and MEN2A Phenotype: Are They All Created Equal?

    • Andreas Machens
    • Henning Dralle

    Endocrine Tumors 16 October 2009 Pages: 331 - 332

50. Reply to, “RET Germline Mutations in Codon 609 and MEN2A Phenotype: Are They All Created Equal?” by Machens and Dralle (ASO-2009-06-0652)

    • Daniel Calva
    • Thomas O’Dorisio
    • James Howe

    Endocrine Tumors 14 October 2009 Pages: 333 - 333